about
Vitamin D deficiency predicts prostate biopsy outcomes.Are HIV-infected men vulnerable to prostate cancer treatment disparities?Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical ProstatectomyExternal validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance.Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.Ex-vivo partial nephrectomy after living donor nephrectomy: Surgical technique for expanding kidney donor pool.Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate.ACTIONS for Men's Health: Development of a Clinically Relevant Men's Health Phenotype and Correlation of Systemic and Urologic Conditions.Robot-assisted ureteral reconstruction - current status and future directions.Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.Robotic-assisted Laparoscopic Bilateral Nerve Sparing and Apex Preserving Cystoprostatectomy in Young Men With Bladder Cancer.More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.Spermatic Vein Thrombosis.Regulating Self-Assembly of Spherical OligomersA Contemporary Analysis of Outcomes and Modifiable Risk Factors of Ethnic Disparities in Kidney TransplantationPrecise Clamping of Renal Artery With Endovascular Stents During Robotic Partial Nephrectomy: Technical Hints to Optimize OutcomesComparative Cost-Effectiveness Analysis of Modified 1-Layer versus Formal 2-Layer Vasovasostomy TechniqueRe: Long-term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate CancerReply to E. Roca et alPrognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceIsolated Right Varicocele and Incidence of Associated CancerCopy number alterations are associated with metastatic-lethal progression in prostate cancerWhat is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients?DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPsAUTHOR REPLYDoes time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?Perioperative Troponin is a Predictor of Both Short- and Intermediate-term Mortality Among Patients Undergoing Major Urologic SurgeryClinicopathologic features and outcomes of anterior-dominant prostate cancer: implications for diagnosis and treatmentOutcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersAssessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancerClinical Predictors of 30-Day Emergency Department Revisits for Patients with Ureteral Stones
P50
Q33923335-0FB202AD-E8C8-4897-8F6C-92182EEF7B05Q34288005-35338ECB-1970-4033-8E6F-0C5039456C69Q36915269-3B4E55F3-2957-44B9-A6AC-46553A0D47C1Q38838706-A8A19A0D-459B-481A-AC98-208EFDC058E2Q40271562-450E8158-75F9-4757-B545-23802ECADC6DQ40411679-481299A0-1466-4971-8C6B-823372A7298EQ40730608-DC14C551-457C-4424-92B3-E0FEBC2CD580Q41882929-3B488978-B22D-4C7C-94AD-6ED3A78ABD07Q46497915-FFA86D6D-BAF2-4BC2-8417-957FF13DE5DEQ47415586-F658E3AF-BD94-4680-9B78-1E624710BBCCQ47642085-D194EA4B-1C2B-4BD9-9547-76443A4BA6D9Q49778510-DEA08220-02A2-4C45-B2B9-1CD08FBF1999Q49892791-7A72654A-2B70-4755-87B0-C3596970453BQ53110288-2CF206DD-4822-49CA-88E4-C5DC9FBB2628Q53776944-E75DD2CF-D866-4FC3-A124-6CC8DF934148Q54238648-E031F34E-AB9D-40AC-89E2-EB86B16A6FA5Q57445709-8779FDA7-58EC-4B91-9922-9B06A3704212Q58610971-E78D4988-CEBF-4EE7-BEA1-EFD473DDAE10Q58855224-3DE54608-6C91-4CC8-AB86-E44F4FD21EB6Q86199854-38D679BE-4FDD-43CC-AC02-8DAE1B7ADB0BQ86455495-179CCC67-9CEB-4783-834A-7AE1E9410887Q88001805-5309F105-12AC-41E6-8A9E-016B3AAF6382Q88335236-2C173156-BE40-448C-A6EB-645F176299BBQ88342913-C1758439-9E1F-4E0C-83E5-0C50F7D023F1Q89767735-3C497DF0-780E-4C97-B817-A849138F3390Q90201838-5C1CA826-61B3-47F9-9E47-93DCEFCAB107Q90742977-2EA97827-7D6D-430A-8F6C-9D30DFD97646Q90831243-964F1DCC-308D-4078-B8E3-C534303FD758Q91090607-F7E4A762-46E5-4CC0-A00A-51E5E92A5E07Q91367124-C56E6B15-E40B-44E3-B2A0-021FEE0FF9B4Q92407193-A27890BF-FA4A-4F1B-AB2B-B11F3DBB49A4Q93036248-3491AA01-6FE1-4BC3-BAB9-53B3D4ADE160Q93163237-51B10091-56CE-4560-A5D9-4779CBF95865Q95355711-AE36A494-F4EA-4F4E-BA2F-01D9E23FAC4D
P50
description
researcher ORCID ID = 0000-0002-8799-6749
@en
wetenschapper
@nl
name
Yaw Nyame
@ast
Yaw Nyame
@en
Yaw Nyame
@es
Yaw Nyame
@nl
type
label
Yaw Nyame
@ast
Yaw Nyame
@en
Yaw Nyame
@es
Yaw Nyame
@nl
prefLabel
Yaw Nyame
@ast
Yaw Nyame
@en
Yaw Nyame
@es
Yaw Nyame
@nl
P106
P31
P496
0000-0002-8799-6749